SBI Healthcare Opportunities Fund - Regular Plan -Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 14-07-1999
AUM:
₹ 5,870 Cr
Expense Ratio
1.99%
Benchmark
BSE Healthcare TRI
ISIN
INF200K01446
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Mr. Tanmaya Desai
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | 13.24 | 22.46 | 17.06 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
494.8033
Last change
13.81 (2.7905%)
Fund Size (AUM)
₹ 5,870 Cr
Performance
15.36% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
To provide the investors with the opportunity of long term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund Manager
Mr. Tanmaya Desai
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 11.14 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 7.91 |
| TREPS | 6.42 |
| Ami Organics Limited | 5.03 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 4.45 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.42 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 4.4 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 4.05 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 3.8 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 3.42 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 93.35 |
| Chemicals | 2.17 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| SBI Healthcare Opportunities Reg Gr | 17.06 |